Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer

Although it has been proposed that the beneficial effect of HER2-targeted therapy in HER2-negative breast cancer is associated with the molecular subtype conversion, the underlying mechanism and the clinical biomarkers are unclear. Our study showed that breast cancer stem cells (BCSCs) mediated HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yun Gyoung, Yoon, Yi Na, Choi, Hyang Suk, Kim, Ji-Hyun, Seol, Hyesil, Lee, Jin Kyung, Seong, Min-Ki, Park, In Chul, Kim, Kwang Il, Kim, Hyun-Ah, Kim, Jae-Sung, Noh, Woo Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814176/
https://www.ncbi.nlm.nih.gov/pubmed/29464036
http://dx.doi.org/10.18632/oncotarget.23528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814176/
https://www.ncbi.nlm.nih.gov/pubmed/29464036
http://dx.doi.org/10.18632/oncotarget.23528

Ejemplares similares